Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Apps

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Brain Pathology (Zurich, Switzerland)|May 9, 2017
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngiomaJessica K R Boult, John R Apps, Annett Hölsken, et al.
Nature Communications|November 29, 2017
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngiomaJose Mario Gonzalez-Meljem, Scott Haston, Gabriela Carreno, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Neuro-Oncology|February 9, 2024
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysisEric W Prince, John R Apps, John Jeang, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Brain Pathology (Zurich, Switzerland)|May 9, 2017
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngiomaJessica K R Boult, John R Apps, Annett Hölsken, et al.
Nature Communications|November 29, 2017
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngiomaJose Mario Gonzalez-Meljem, Scott Haston, Gabriela Carreno, et al.
Acta Neuropathologica Communications|August 10, 2024
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progressionJohn R Apps, Jose Mario Gonzalez-Meljem, Romain Guiho, et al.
Neuro-Oncology|February 9, 2024
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysisEric W Prince, John R Apps, John Jeang, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 3